Raleigh, NC, United States of America

David C Muddiman

This inventor holds 4 USPTO granted patents. Top assignee: Mayo Foundation for Medical Education and Research. Active years: 2006-2012.

IDiyas Innovation Intelligence. (2026). Inventor Profile: David C Muddiman. Retrieved from https://idiyas.com/inventor/david-c-muddiman

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


% Patents Active = 75.0

Average Co-Inventor Count = 3.7

ph-index = 1

Forward Citations = 7(Granted Patents)


Location History:

  • Rochester, MN (US) (2006)
  • Raleigh, NC (US) (2009 - 2012)

Company Filing History:


Years Active: 2006-2012

Loading Chart...
4 patents (USPTO):Explore Patents

Title: The Innovative Contributions of David C. Muddiman

Introduction

David C. Muddiman is a notable inventor based in Raleigh, NC (US). He has made significant contributions to the field of medical research, particularly in the development of vaccines and diagnostic methods. With a total of 4 patents to his name, Muddiman's work has the potential to impact public health positively.

Latest Patents

Muddiman's latest patents include groundbreaking research on naturally processed measles virus peptides from class II HLA molecules. This patent discloses a preparation of peptides eluted from class II HLA molecules. It also outlines methods for decreasing measles infections by inoculating human patients with a vaccine comprising one or more of these peptides. Additionally, it describes methods for diagnosing measles infections or immunity by analyzing human patients for the presence of these peptides or antibodies to them.

Another significant patent involves a peptide originating from the vaccinia virus. This patent presents a vaccine designed to prevent or treat Orthopoxvirus infection. The vaccine induces a protective or therapeutic immune response and comprises an amino acid sequence of 20 amino acids or less. It also includes an antigen-presenting cell pulsed with the peptide or a cell sensitized in vitro to the peptide.

Career Highlights

David C. Muddiman is affiliated with the Mayo Foundation for Medical Education and Research. His work at this esteemed institution has allowed him to focus on innovative research that bridges the gap between laboratory findings and clinical applications. His contributions have been instrumental in advancing the understanding of viral infections and their treatments.

Collaborations

Muddiman has collaborated with notable colleagues, including Gregory A. Poland and Inna G. Ovsyannikova. These collaborations have fostered a rich environment for research and innovation, leading to advancements in vaccine development and infectious disease management.

Conclusion

David C. Muddiman's innovative work in the field of medical research exemplifies the impact that dedicated inventors can have on public health. His patents and collaborations continue to pave the way for new solutions in combating viral infections.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…